Harmony Biosciences Growth, Revenue, Number of Employees and Funding

Overview

Location:
Total Funding:$495M
Industry:Biotech
Founded:2017
Lead Investor(s):CR Group LP
Press

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Harmony Biosciences's estimated revenue is currently $21.5M per year.
  • Harmony Biosciences received $200.0M in venture funding in March 2019.
  • Harmony Biosciences's estimated revenue per employee is $144597
  • Harmony Biosciences's total funding is $495M.

Employee Data

  • Harmony Biosciences has 149 Employees.
  • Harmony Biosciences grew their employee count by 166% last year.
  • Harmony Biosciences currently has 2 job openings.

Executive Contacts

NameTitle
Cate McCanlessVice President External Affairs
Julie BrownStrategic Market Director-National & Regional Accounts
Michele KempDirector, Patient Engagement
Kate HollandVP, Patient Engagement & Digital Marketing
David KnouftVice President, U.S. Market Access
Jill CharbonneauDirector Regulatory Affairs
Jeffrey DaynoExecutive Vice President and Chief Medical Officer
Michele RoyVice President, Regulatory Affairs
Joyce ErcolinoDirector, Digital Excellence
Matt FenskeVice President Lifecycle & Portfolio Strategy

What Is Harmony Biosciences?

Patients are at the beginning, middle, and heart of all we do. Harmony Biosciences, LLC, is a privately-owned biopharmaceutical company. The company was established in October 2017 with a vision to provide novel treatment options for people living with rare and orphan diseases with an emphasis on central nervous system disorders, starting with a focus on helping patients who live with narcolepsy. Harmony Biosciences is committed to advancing the understanding of narcolepsy and providing information and resources to individuals who live with, and healthcare professionals who treat, patients with narcolepsy.

keywords:N/A

149

Number of Employees

$21.5M

Revenue (est)

2

Current Jobs

166%

Employee Growth %

$495M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Rockland Immuno...
$13.2M9112%
Braeburn
$9M62-29%$133M
DrugScan
$20.9M144-5%
TechData Servic...
$10.4M72-1%
HERO BX
$6M4220%
PhaseBio Pharma...
$5.3M3644%
Harmony Bioscie...
$21.5M149166%$495M
Tmunity Therape...
$8.7M6054%$150M
Krystal Biotech
$7.1M4948%
BioTelemetry
$377.3M24122%

Harmony Biosciences News

08/17/2019 - Harmony Biosciences set to launch excessive daytime ...

Harmony Biosciences, LLC (Harmony) has announced that the U.S. Food and Drug Administration (FDA) approved WAKIX® (pitolisant) for the ...

08/15/2019 - Harmony Biosciences Announces FDA Approval Of WAKIX ...

PLYMOUTH MEETING, Pa., Aug. 15, 2019 /PRNewswire/ -- Harmony Biosciences, LLC (Harmony) announced today that the U.S. Food and ...

08/12/2019 - FDA decision on Montco firm's sleep disorder drug expected ...

The Plymouth Meeting company is seeking approval of its experimental therapy targeting narcolepsy and cataplexy.

Harmony Biosciences Funding

DateAmountRoundLead InvestorsReference
2017-10-09$270.0MUndisclosedArticle
2019-03-14$200.0MUndisclosedCR Group LPArticle

Harmony Biosciences New Location/Offices

DateLocationReference
2018-09-14Philadelphia, PAArticle